Table 2.

Main published studies on discontinuation of TPO-RAs in patients with ITP.

Study	Number of patients	Patients who discontinued TPO-RA (n, % from all pts)	Patients in sustained remission (n, % of all patients)	Median follow-up (months)
Newland et al. 37	75	31 (41)	24 (32)	6
Ghadaki et al. 38	31	9 (29)	5 (16)	9.5
González-Lopez et al. 39	201	80 (39)	42 (21)	9
Mahevas et al. 40	54	20 (37)	8 (15)	13.5
Cervinek et al. 34	46	11 (24)	11 (24)	33
Marshall et al. 41	43	12 (28)	12 (28)	33

ITP, immune thrombocytopenia; TPO-RA, thrombopoietin receptor agonists.